IBI363 PD-1/IL2α bispecific FDA Fast Track Designation for Advanced/Metastatic #Melanoma (DCR) 73.0%. Among 8 immuno-oncology (IO)–naive patients with #mucosalmelanoma, ORR was 75.0%, including 1 CR and 5 PRs. The DCR in this population was 100%. Innovent Melanoma Research Foundation

Man murders Olympic athlete by burning her alive. Fixed it for you.

Hot off the press: Real-world treatment patterns and outcomes in patients with HR+/HER2− metastatic breast cancer treated with chemotherapy in the United States - by Sara Tolaney et al. esmoopen.com/article/S2059-…

Two years later, on Sept 15th #ESMO24, I will present the long awaited 3-year DFS data for NICHE-2 ‼️ But that’s not all…exciting🩸ctDNA dynamics included. See you there! ESMO - Eur. Oncology The Netherlands Cancer Institute

ICYMI: A recording from the recent #CancerMoonshot workshop is now available. Learn more about opportunities to help advance #AI in #CancerResearch: datascience.cancer.gov/news-events/ev…

Make sure to watch the recording if you missed the initial event!

Very proud to be the first cancer researcher to receive this national award. Clearly exercise oncology is mainstream!

Frequency of HER2 alterations across tumor types & current development landscape of HER2-targeted therapies summarized in this publication. nature.com/articles/s4157…

Getting ready for an exciting #WCLC24 with friends! Always great to connect with Pasi Janne Christine Lovly, MD, PhD Tina Cascone Sandip Patel MD but even more so in sunny San Diego!

I'm really pumped for all the new data to be presented at the 50th #WCLC24 in #SanDiego! There are WAY too many EXCELLENT orals, mini-orals, and posters to cover; I'm only going to a highlight a few of the plenaries and orals I'm most excited about [THREAD]

The FDA has accepted a supplemental biologics license application for nivolumab plus ipilimumab for first-line unresectable hepatocellular carcinoma. #oncology #HCC #MedEd onclive.com/view/fda-accep…

A new generation of vaccine #adjuvants tailored for the pediatric immune system could help overcome longstanding gaps in the design of #InfectiousDisease vaccines for children, according to a new Viewpoint from researchers at NIAID News. scim.ag/8hu

Dr. Stephanie Seidlits (Stephanie Seidlits) et al. UT Austin #CancerTEC are using #TissueEngineered models of #glioblastoma to investigate the role of the #BrainTumor microenvironment on cancer cell migration and invasion. cancer.gov/about-nci/orga… #BTSM

Congratulations and heartfelt thanks to the #WCLC24 chairs for curating such a special meeting for #IASLC50 - Drs. Sandip Patel MD Linda Martin Dr. Fabio Moraes and the inimitable Narjust Florez, MD, FASCO!

Moving story from Narjust Florez, MD, FASCO’s own mother about her experience with #lungcancer #WCLC24 #esperanza

Congratulations to Dr. Julie Brahmer Dr. Julie Brahmer - this year’s Paul A. Bunn Jr. Scientific Award winner for lifetime achievement and we’re ready to celebrate at #WCLC24!

Congratulation to my colleague Dr. Claudia Henschke for getting IASLC Distinguished Award at WCLC 2024.

HUGE Congratulations to Dr. Dr. Julie Brahmer a pioneer in immunotherapy in #LungCancer & outstanding mentor & role model for so many of us #WCLC24 #LCSM

As always, IASLC CEO Dr. Karen Kelly delivers focus and enthusiasm for the coming years

20 years of #lungcancer as a poster child for #precisionmedicine. But our work is far from done. #WCLC24 Great talk by Dr. Lowy. #LCSM